Emily Field, head of European pharmaceuticals research at Barclays, weighs in on rising competition in the global obesity ...

CNBC’s Deirdre Bosa, Big Technology’s Alex Kantrowitz and Wealth Enhancement’s Ayako Yoshioka, join 'Closing Bell' to discuss ...

Merck's latest earnings call revealed a mix of growth and pain points for the pharmaceutical giant.

A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii).

Conduit and Sarborg complete all milestones of Phase I of their AI-driven drug development collaboration, and commence transitioning to Phase II, ...

A groundbreaking cannabinoid-based antimicrobial, Silvanex, fights drug-resistant infections with a synergy of silver, CBC ...

There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...

Residents testified they were concerned about drug rehab patients wandering into Century Village late at night and breaking into condos.

I’m perfectly happy for the wizards to help me out in drug development and help speed medicines to […] the right patients,” he said. Oncology researcher Pierce works at Owkin, a Paris-based ...